QR Code

Charge Transfer Complex of Lorlatinib with Chloranilic Acid: Characterization and Application to the Development of a Novel 96-Microwell Spectrophotometric Assay with High Throughput

Lorlatinib (LRL) is the first drug of the third generation of anaplastic lymphoma kinase (ALK) inhibitors used a first-line treatment of non-small cell lung cancer (NSCLC). This study describes, for the first time, the investigations for the formation of a charge transfer complex (CTC) between LRL,...

Full description

Saved in:
Bibliographic Details
Main Authors: Hany W. Darwish, Ibrahim A. Darwish, Awadh M. Ali, Halah S. Almutairi
Format: Artigo
Language:Inglês
Published: MDPI AG 2023-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/9/3852
Tags: Add Tag
No Tags, Be the first to tag this record!